More than 180 COVID-19 vaccines are in various stages of development, including several currently being tested for safety and efficacy. Some experts expect a vaccine to be available in the next few months. However, ready acceptance of such a vaccine remains unknown. A recent poll suggests that sixty percent of Americans report that they do not want to take a COVID-19 vaccine as soon as one is available. What might such hesitancy mean for curbing the current pandemic? How might slow acceptance impact communities with historically lower general vaccination rates? And what role do seasonal flu vaccination campaigns play in setting the stage for COVID-19 vaccine acceptance? In this Facebook Live Q&A, The World’s Elana Gordon discussed COVID-19 vaccine acceptance with Howard Koh, Harvey V. Fineberg Professor of the Practice of Public Health Leadership at the Harvard Chan School and the Harvard Kennedy School, as well as the 14th Assistant Secretary for Health for the U.S. Department of Health and Human Services.
This event was presented jointly by The Forum at the Harvard T.H. Chan School of Public Health and The World from PRX & GBH on October 2, 2020.
Related Posts
